Gel cushion may shield rectum during prostate cancer radiation

NCT ID NCT05323747

Completed Disease control Sponsor: BioProtect Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested a hydrogel spacer placed between the prostate and rectum in 20 men undergoing radiation for prostate cancer. The goal was to see if the spacer reduces radiation reaching the rectum. Researchers compared rectal radiation exposure before and after inserting the spacer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hydrogel spacer
What this could lead to: If successful, this spacer could help reduce rectal damage during prostate cancer radiation, making treatment safer.
What could go wrong: This is a small, early study with only 20 participants. It only measures radiation exposure, not long-term patient outcomes or side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Northern Nevada Radiation Oncology

Reno, Nevada, 89521, United States
Western Radiation Oncology

Campbell, California, 95008, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.